Class information for:
Level 1: GENE THER Y SCI//RECOMBINANT SENDAI VIRUS//HVJ E

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
27919 218 39.7 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
419 3       ADENOVIRUS//MERKEL CELL CARCINOMA//GENE THERAPY 28518
564 2             GENE THERAPY//ADENOVIRUS//HUMAN GENE THERAPY 14456
27919 1                   GENE THER Y SCI//RECOMBINANT SENDAI VIRUS//HVJ E 218

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENE THER Y SCI address 744914 20% 12% 44
2 RECOMBINANT SENDAI VIRUS authKW 720361 3% 86% 6
3 HVJ E authKW 689572 4% 62% 8
4 SENDAI VIRUS STRAIN TIANJIN authKW 560282 2% 100% 4
5 SENDAI VIRUS authKW 460032 14% 11% 30
6 HVJ authKW 457556 3% 47% 7
7 CYTOPLASMIC RNA VECTOR authKW 420212 1% 100% 3
8 INACTIVATED SENDAI VIRUS HVJ E authKW 420212 1% 100% 3
9 SENDAI VIRUS VECTOR authKW 403725 3% 41% 7
10 FUBP1 authKW 389081 2% 56% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Medicine, Research & Experimental 717 22% 0% 48
2 Genetics & Heredity 518 21% 0% 46
3 Biotechnology & Applied Microbiology 451 20% 0% 44
4 Oncology 415 24% 0% 52
5 Biochemistry & Molecular Biology 341 35% 0% 76
6 Cell Biology 280 20% 0% 43
7 Virology 78 5% 0% 11
8 Cell & Tissue Engineering 78 2% 0% 4
9 Biophysics 32 6% 0% 12
10 Transplantation 28 3% 0% 6

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENE THER Y SCI 744914 20% 12% 44
2 CLIN GENET PROTE 249010 2% 44% 4
3 RD INNOVAT BIOTHER EUT 214472 3% 22% 7
4 PROTEOME PROJECT 186759 1% 67% 2
5 VIRAL INFECT VACCINE CONTROL 186759 1% 67% 2
6 21 CENTURY COE PROGRAMCHUO KU 140071 0% 100% 1
7 ABT VIRUSFO 140071 0% 100% 1
8 CENTURY COE PROGRAM 21CHUO KU 140071 0% 100% 1
9 FIELDS TISSUE ENGN FRONTIER MED SCI 140071 0% 100% 1
10 FIELS TISSUE ENGN FRONTIER MED SCI 140071 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENE THERAPY 10335 8% 0% 17
2 JOURNAL OF GENE MEDICINE 3580 3% 0% 6
3 CURRENT GENE THERAPY 2294 1% 1% 3
4 NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES 1557 1% 1% 2
5 MOLECULAR THERAPY 1414 3% 0% 6
6 CANCER SCIENCE 987 2% 0% 5
7 FRONTIERS IN BIOSCIENCE-LANDMARK 973 2% 0% 5
8 CELL TRANSPLANTATION 837 2% 0% 4
9 MOLECULAR UROLOGY 798 0% 1% 1
10 HUMAN GENE THERAPY 666 2% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 RECOMBINANT SENDAI VIRUS 720361 3% 86% 6 Search RECOMBINANT+SENDAI+VIRUS Search RECOMBINANT+SENDAI+VIRUS
2 HVJ E 689572 4% 62% 8 Search HVJ+E Search HVJ+E
3 SENDAI VIRUS STRAIN TIANJIN 560282 2% 100% 4 Search SENDAI+VIRUS+STRAIN+TIANJIN Search SENDAI+VIRUS+STRAIN+TIANJIN
4 SENDAI VIRUS 460032 14% 11% 30 Search SENDAI+VIRUS Search SENDAI+VIRUS
5 HVJ 457556 3% 47% 7 Search HVJ Search HVJ
6 CYTOPLASMIC RNA VECTOR 420212 1% 100% 3 Search CYTOPLASMIC+RNA+VECTOR Search CYTOPLASMIC+RNA+VECTOR
7 INACTIVATED SENDAI VIRUS HVJ E 420212 1% 100% 3 Search INACTIVATED+SENDAI+VIRUS+HVJ+E Search INACTIVATED+SENDAI+VIRUS+HVJ+E
8 SENDAI VIRUS VECTOR 403725 3% 41% 7 Search SENDAI+VIRUS+VECTOR Search SENDAI+VIRUS+VECTOR
9 FUBP1 389081 2% 56% 5 Search FUBP1 Search FUBP1
10 FUSE BINDING PROTEIN 373519 2% 67% 4 Search FUSE+BINDING+PROTEIN Search FUSE+BINDING+PROTEIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DUAN, JY , BAO, X , MA, X , ZHANG, Y , NI, D , WANG, HF , ZHANG, F , DU, QS , FAN, Y , CHEN, JW , ET AL (2017) UPREGULATION OF FAR UPSTREAM ELEMENT-BINDING PROTEIN 1 (FUBP1) PROMOTES TUMOR PROLIFERATION AND TUMORIGENESIS OF CLEAR CELL RENAL CELL CARCINOMA.PLOS ONE. VOL. 12. ISSUE 1. P. - 29 53% 0
2 ZHOU, WX , CHUNG, YJ , CASTELLAR, ERP , ZHENG, Y , CHUNG, HJ , BANDLE, R , LIU, JH , TESSAROLLO, L , BATCHELOR, E , APLAN, PD , ET AL (2016) FAR UPSTREAM ELEMENT BINDING PROTEIN PLAYS A CRUCIAL ROLE IN EMBRYONIC DEVELOPMENT, HEMATOPOIESIS, AND STABILIZING MYC EXPRESSION LEVELS.AMERICAN JOURNAL OF PATHOLOGY. VOL. 186. ISSUE 3. P. 701 -715 28 54% 0
3 MATSUSHITA, K , SHIMADA, H , UEDA, Y , INOUE, M , HASEGAWA, M , TOMONAGA, T , MATSUBARA, H , NOMURA, F , (2014) NON-TRANSMISSIBLE SENDAI VIRUS VECTOR ENCODING C-MYC SUPPRESSOR FBP-INTERACTING REPRESSOR FOR CANCER THERAPY.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 15. P. 4316-4328 21 60% 2
4 ZHANG, J , CHEN, QM , (2013) FAR UPSTREAM ELEMENT BINDING PROTEIN 1: A COMMANDER OF TRANSCRIPTION, TRANSLATION AND BEYOND.ONCOGENE. VOL. 32. ISSUE 24. P. 2907 -2916 31 33% 26
5 HSIAO, HH , NATH, A , LIN, CY , FOLTA-STOGNIEW, EJ , RHOADES, E , BRADDOCK, DT , (2010) QUANTITATIVE CHARACTERIZATION OF THE INTERACTIONS AMONG C-MYC TRANSCRIPTIONAL REGULATORS FUSE, FBP, AND FIR.BIOCHEMISTRY. VOL. 49. ISSUE 22. P. 4620-4634 22 42% 20
6 TANAKA, N , ARAKI, K , MIZOKAMI, D , MIYAGAWA, Y , YAMASHITA, T , TOMIFUJI, M , UEDA, Y , INOUE, M , MATSUSHITA, K , NOMURA, F , ET AL (2015) SENDAI VIRUS-MEDIATED GENE TRANSFER OF THE C-MYC SUPPRESSOR FAR-UPSTREAM ELEMENT-BINDING PROTEIN-INTERACTING REPRESSOR SUPPRESSES HEAD AND NECK CANCER.GENE THERAPY. VOL. 22. ISSUE 4. P. 297 -304 17 46% 1
7 HAUCK, S , HIESINGER, K , HOSSEINI, SK , ACHENBACH, J , BIONDI, RM , PROSCHAK, E , ZORNIG, M , ODADZIC, D , (2016) PYRAZOLO[1,5A]PYRIMIDINES AS A NEW CLASS OF FUSE BINDING PROTEIN 1 (FUSP1) INHIBITORS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 24. ISSUE 22. P. 5717 -5729 14 54% 0
8 MATVEEVA, OV , KOCHNEVA, GV , NETESOV, SV , ONIKIENKO, SB , CHUMAKOV, PM , (2015) MECHANISMS OF ONCOLYSIS BY PARAMYXOVIRUS SENDAI.ACTA NATURAE. VOL. 7. ISSUE 2. P. 6 -16 21 33% 1
9 MIZOKAMI, D , ARAKI, K , TANAKA, N , SUZUKI, H , TOMIFUJI, M , YAMASHITA, T , UEDA, Y , SHIMADA, H , MATSUSHITA, K , SHIOTANI, A , (2015) GENE THERAPY OF C-MYC SUPPRESSOR FUSE-BINDING PROTEIN-INTERACTING REPRESSOR BY SENDAI VIRUS DELIVERY PREVENTS TRACHEAL STENOSIS.PLOS ONE. VOL. 10. ISSUE 1. P. - 15 41% 2
10 KINOH, H , INOUE, M , (2008) NEW CANCER THERAPY USING GENETICALLY-ENGINEERED ONCOLYTIC SENDAI VIRUS VECTOR.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 13. ISSUE . P. 2327 -2334 12 55% 14

Classes with closest relation at Level 1


Rank Class id link
1 33088 VIROSOMES//FUSOGENIC LIPOSOME//FRAGMENT A OF DIPHTHERIA TOXIN
2 16206 GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS
3 5700 V PROTEIN//CHANDIPURA VIRUS//PARAMYXOVIRUS
4 20621 HNRNP K//VIGILIN//HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K
5 9263 HUMAN PARAINFLUENZA VIRUS//PORCINE RUBULAVIRUS//PARAMYXOVIRUS
6 28292 RETICULOCALBIN//CALUMENIN//BIOCHEM BIOMOL RECOGNIT
7 30236 HERBOXIDIENE//SPLICEOSTATIN A//FR901464
8 25646 DEV MODEL//NEW YORK EXCELLENCE INFLUENZA SURVEILLA//MINI PLASMIN
9 1198 MYC//MAX//C MYC
10 24918 TRANSCRIPTION FACTOR DECOY//DECOY//NF KAPPA B DECOY

Go to start page